A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.

Clinical trial NCT05338086 · COMPLETED

Trial details

NCT number: NCT05338086
Sponsor: mAbxience Research S.L.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Women With Osteoporosis

Start date: 2022-03-16
Primary completion: 2023-12-14
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.